✦ LIBER ✦

Should heart transplantation be considered as a treatment option for patients aged 70 years and older?

✍ Scribed by Jeffrey A Morgan; Ranjit John; Donna M Mancini; Niloo M Edwards

Book ID: 113759461
Publisher: CTSNet
Year: 2004
Tongue: English
Weight: 74 KB
Volume: 127
Category: Article
ISSN: 1097-685X
DOI: 10.1016/j.jtcvs.2003.12.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Heart Transplantation in Patients Aged 7

Heart Transplantation in Patients Aged 70 Years and Older: A Two-Decade Experience

✍ D. Daneshvar; L.S.C. Czer; A. Phan; E.R. Schwarz; M. De Robertis; J. Mirocha; M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Should chemotherapy be used as a treatme

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?: Pro:

✍ B. Daniele 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Should chemotherapy be used as a treatme

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?: Contra:

✍ P.D Simmonds; L.Y Best 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Should chemotherapy be used as a treatme

Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?: Arbiter:

✍ P.J. Ross; D. Cunningham 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 70 KB

A phase II study of a THP-COP regimen fo

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

✍ Hisashi Tsurumi; Takeshi Hara; Naoe Goto; Nobuhiro Kanemura; Senji Kasahara; Mic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

## Abstract Pirarubicin (tetrahydropyranyl adriamycin: THP) is an anthracycline drug that reportedly has fewer cardiotoxic effects than doxorubicin. A phase II study was conducted in order to determine the efficacy of a treatment regimen incorporating THP, namely THP‐COP in the treatment of elderly

Hematopoietic cell transplantation from

Hematopoietic cell transplantation from unrelated and related donors after a fludarabine-alkylator-based regimen is a reasonable treatment option for older patients (>60 years) with active hematologic malignancies

✍ J. Finke; A. Spyridonidis; G. Ihorst; C. Gruellich; R. Zeiser; H. Bertz 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 58 KB